Glass House Brands GLAS
NYSE GLAS
$9.38 -0.32 (-3.30%)
At close: Aug 20, 2026 · 12:59 PM UTC

Glass House Brands (GLAS) Income towards Parent Company (2020 - 2026)

Glass House Brands (GLAS) posted quarterly Income towards Parent Company of -$17.0 million for Q1 2026, down 9.72% quarter-over-quarter from -$15.5 million in Q4 2025.

Glass House Brands (GLAS) Income towards Parent Company (2020 - 2026) Analysis & Trends

Glass House Brands (GLAS) has reported Income towards Parent Company for 7 consecutive years, with -$17.0 million the latest figure, recorded in Q1 2026.

  • In Q1 2026, Income towards Parent Company changed N/A year-over-year to -$17.0 million; the TTM figure through Mar 2026 stood at -$36.0 million (down 460.39% YoY), while the FY2025 annual figure was -$29.0 million, down 4115.53% from the prior year.
  • Income towards Parent Company eased to -$17.0 million in Q1 2026 per GLAS's latest filing, from -$15.5 million in the prior quarter.
  • Across five years, Income towards Parent Company topped out at $15.2 million in Q3 2022 and bottomed at -$19659.4 billion in Q2 2023.
  • Historically, Income towards Parent Company has averaged -$2470.7 billion across 5 years, with a median of -$17.0 million in 2026.
  • Annual changes were most pronounced in 2022 — Income towards Parent Company surged 100.0% — and 2023, when it slumped 58.76%.
  • Glass House Brands' Income towards Parent Company stood at -$28.4 million in 2022, then plunged by 49.89% to -$42.6 million in 2023, then jumped by 123.47% to $10.0 million in 2024, then tumbled by 255.06% to -$15.5 million in 2025, then dropped by 9.72% to -$17.0 million in 2026.
  • Business Quant data shows GLAS's Income towards Parent Company at -$17.0 million in Q1 2026, -$15.5 million in Q4 2025, and -$12.2 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 43.96 Bn 43.00 Bn -
2 Teva Pharmaceutical Industries 43.23 Bn 39.58 Bn 2.15 Bn
3 Zoetis 31.76 Bn 30.08 Bn 1.05 Bn
4 Takeda Pharmaceutical 28.68 Bn 22.88 Bn 5.10 Bn
5 United Therapeutics 22.27 Bn 19.61 Bn 683.80 Mn
6 Viatris 18.69 Bn 17.81 Bn 1.46 Bn
7 Neurocrine Biosciences 15.56 Bn 15.17 Bn 935.80 Mn
8 Elanco Animal Health 11.78 Bn 11.25 Bn 798.00 Mn
9 Dr Reddys Laboratories 10.13 Bn 9.97 Bn -
10 Glass House Brands 829.33 Mn 810.78 Mn 15.77 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -17.01 Mn
Dec 31, 2025 -15.50 Mn
Sep 30, 2025 -12.19 Mn
Jun 30, 2025 8.67 Mn
Jun 30, 2024 10.00 Mn
Dec 31, 2023 -42.60 Mn
Sep 30, 2023 6.28 Mn
Jun 30, 2023 -19,659.40 Bn
Mar 31, 2023 -32.41 Mn
Dec 31, 2022 -28.42 Mn
Sep 30, 2022 15.17 Mn
Jun 30, 2022 -12,459.44 Bn
Mar 31, 2022 -20.41 Mn
Dec 31, 2021 -22.46 Mn
Sep 30, 2021 -6,955.68 Bn
Jun 30, 2021 -13,606.55 Bn
Mar 31, 2021 -13.15 Mn
Dec 31, 2020 -23,713.35 Bn
Sep 30, 2020 -1.15 Mn
Mar 31, 2020 -5.14 Mn